Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Nuance Matters

Journal of Thoracic Oncology

English

MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-Pd-1

Journal of Thoracic Oncology

English

MA13.09 Electromagnetic Navigation Bronchoscopy as an Integrated Approach to Aid in Diagnosis and Treatment of Pulmonary Lesions

Journal of Thoracic Oncology

English

P1.13-03 Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.01-107 Correlation Study of Bone Metastasis and Cholesterol Level in Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P1.01-07 Immune-Related Pneumonitis in NSCLC Patients Treated With Immune Checkpoint Inhibitors (ICI): Impact of Previous Thoracic Radiotherapy

Journal of Thoracic Oncology

English

P3.01-76 Clinical Background and Response to Chemotherapy in NSCLC Patients With MET Exon14 Skipping Mutation or High MET Gene Copy Number

Journal of Thoracic Oncology

English

Distinct Clinicopathological Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical-Stage IA Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy

Journal of Thoracic Oncology

English

P2.16-50 Do Patients Have Preconceived Ideas on Various Surgical Approaches? Patient Perspective: Open vs. Minimally Invasive Surgery (PROMIS) Survey

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Nuance Matters

MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-Pd-1

MA13.09 Electromagnetic Navigation Bronchoscopy as an Integrated Approach to Aid in Diagnosis and Treatment of Pulmonary Lesions

P1.13-03 Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer

P3.01-107 Correlation Study of Bone Metastasis and Cholesterol Level in Patients With Lung Adenocarcinoma

P1.01-07 Immune-Related Pneumonitis in NSCLC Patients Treated With Immune Checkpoint Inhibitors (ICI): Impact of Previous Thoracic Radiotherapy

P3.01-76 Clinical Background and Response to Chemotherapy in NSCLC Patients With MET Exon14 Skipping Mutation or High MET Gene Copy Number

Distinct Clinicopathological Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical-Stage IA Lung Adenocarcinoma

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy

P2.16-50 Do Patients Have Preconceived Ideas on Various Surgical Approaches? Patient Perspective: Open vs. Minimally Invasive Surgery (PROMIS) Survey